Product Information
GNP TUSSIN LONG-ACTING LIQUID is a generic product labeled by AmerisourceBergen, priced at $0.0226 per ML under NDC 46122078429. Its NADAC has been published 46 times since Nov 19, 2025.
Strength
30 mg/10mL
Manufacturer
AmerisourceBergenNDC
46122078429
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/24/2024
Pharmacological Classes
Price Statistics
The NADAC for GNP TUSSIN LONG-ACTING LIQUID has been published 46 times since Nov 19, 2025, and over the history we have for it it has risen 3.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0226 per ML |
|---|---|
| All-time high | $0.0232 (Aug 12, 2026) |
| All-time low | $0.0215 (Jan 21, 2026) |
| 52-week high | $0.0232 |
| 52-week low | $0.0215 |
| Median price | $0.0224 |
| Average price | $0.0223 |
| Largest weekly change | +2.3% (May 20, 2026) |
| Weeks tracked | 46 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP TUSSIN LONG-ACTING LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for GNP TUSSIN LONG-ACTING LIQUID, manufactured by AmerisourceBergen, is $0.0226 per ML (NDC 46122078429), effective Sep 30, 2026.
How has the price of GNP TUSSIN LONG-ACTING LIQUID changed over time?
Over the history we have for it, the NADAC for GNP TUSSIN LONG-ACTING LIQUID has risen 3.9%. It has been tracked across 46 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for GNP TUSSIN LONG-ACTING LIQUID?
Since Nov 19, 2025, the NADAC for GNP TUSSIN LONG-ACTING LIQUID has ranged from a low of $0.0215 (Jan 21, 2026) to a high of $0.0232 (Aug 12, 2026), with a median of $0.0224 per ML.
Are there cheaper alternatives to GNP TUSSIN LONG-ACTING LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of GNP TUSSIN LONG-ACTING LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP TUSSIN LONG-ACTING LIQUID?
GNP TUSSIN LONG-ACTING LIQUID (NDC 46122078429) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.